Citi analyst Joanne Wuensch raised the firm’s price target on Becton Dickinson to $282 from $260 and keeps a Neutral rating on the shares. The analyst adjusted price targets in the medical technology space post the Q2 reports.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BDX:
- Jefferies healthcare analysts to hold an analyst/industry conference call
- Becton Dickinson price target raised to $303 from $284 at Barclays
- Becton Dickinson backs FY23 adjusted EPS view $12.10-$12.32, consensus $12.22
- Becton Dickinson reports Q3 adjusted EPS $2.96, consensus $2.91
- BD Reports Third Quarter Fiscal 2023 Financial Results
